Fisher Asset Management’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$234K Buy
3,659
+443
+14% +$29.1K ﹤0.01% 985
2026
Q1
$229K Sell
3,216
-6,513
-67% -$514K ﹤0.01% 954
2025
Q4
$798K Buy
9,729
+5,175
+114% +$403K ﹤0.01% 709
2025
Q3
$342K Buy
4,554
+4
+0.1% +$298 ﹤0.01% 856
2025
Q2
$337K Buy
4,550
+444
+11% +$30.9K ﹤0.01% 862
2025
Q1
$331K Buy
4,106
+482
+13% +$41.4K ﹤0.01% 879
2024
Q4
$283K Buy
3,624
+233
+7% +$19.8K ﹤0.01% 883
2024
Q3
$318K Sell
3,391
-1,082
-24% -$90.8K ﹤0.01% 823
2024
Q2
$349K Sell
4,473
-1
-0% -$82 ﹤0.01% 855
2024
Q1
$407K Sell
4,474
-301
-6% -$25K ﹤0.01% 807
2023
Q4
$369K Buy
4,775
+535
+13% +$37.5K ﹤0.01% 828
2023
Q3
$289K Sell
4,240
-169
-4% -$12.3K ﹤0.01% 943
2023
Q2
$358K Sell
4,409
-852
-16% -$68K ﹤0.01% 918
2023
Q1
$432K Buy
+5,261
New +$376K ﹤0.01% 869

Other funds holding GEHC

Fisher Asset Management's GEHC Position: Q2 2026 in Review

Fisher Asset Management increased its GE HealthCare (GEHC) stake by 14% in Q2 2026, buying an estimated $29.1K and bringing the position to 3,659 shares worth $234K. The position accounts for ﹤0.01% of the portfolio, ranked #985.

Fisher Asset Management first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $798K in Q4 2025. 1,223 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Fisher Asset Management held 3,659 shares of GE HealthCare worth $234K as of Q2 2026.
  • Fisher Asset Management bought 443 GE HealthCare shares in Q2 2026, an estimated $29.1K.
  • GE HealthCare made up ﹤0.01% of Fisher Asset Management's portfolio in Q2 2026, its #985 holding.
  • Fisher Asset Management first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • Fisher Asset Management's GE HealthCare position peaked at $798K in Q4 2025.
  • 1,223 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Fisher Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.